Table 5.
Overall | Depression, anxiety, and/or PTSD | P-value | ||
---|---|---|---|---|
Absent | Present | |||
N | 55 | 42 | 13 | – |
Health Utilization | ||||
Physician visits, median | 5 | 4 | 9 | 0.06‡ |
ED visits, median | 0 | 0 | 0 | 0.44‡ |
Hospitalizations, | 0 | 0 | 0 | 0.39‡ |
median | ||||
Nights in the | 0 | 0 | 0 | 0.36‡ |
hospital, median | ||||
Good functional outcome (mRS 0–2) | 86% | 95% | 54% | <0.01† |
Euroqol: Subjects Reporting Any Problem | ||||
Mobility | 46% | 33.3% | 84.6% | <0.01† |
Self Care | 20% | 9.5% | 53.9% | <0.01† |
Usual activities | 47% | 38.1% | 76.9% | 0.02† |
Pain | 53% | 47.6% | 69.2% | 0.22† |
Anxiety/depression | 48% | 21.4% | 76.9% | <0.01† |
Overall QOL Visual Analog Scale, median (IQR) | 80 (60–90) | 80 (60–90) | 50 (50–60) | <0.01‡ |
PTSD, post traumatic stress disorder; ED; Emergency department; mRS, modified Rankin Scale; QOL, quality of life; IQR, interquartile range.
Fisher's exact test.
Wilcoxon Rank Sum.